Mirae Asset Global Investments Co., Ltd. Biomarin Pharmaceutical Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,590 shares of BMRN stock, worth $473,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,590
Previous 8,404
9.69%
Holding current value
$473,919
Previous $590,000
15.59%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding BMRN
# of Institutions
645Shares Held
178MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.42 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.2 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.18 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$868 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$655 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...